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Abstract  
Introduction: Chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) is the most 
common leukemia of adult. Patients with CLL/SLL are at higher risk for secondary malignancies such as 
skin, breast or lung tumours. Cutaneous infiltrates of CLL/SLL have been reported in association with 
squamous cell carcinoma (SCC), basal cell carcinoma (BCC) and actinic keratosis.  
Case Presentation: We present a patient with a previous history of CLL/SLL who developed a primary 
skin melanoma in the same area of leukemic infiltration, with the histological and immunohistochemical 
features.  
An 80-year-old man presented with an 3 cm nonpigmented, erythematous and ulcerated plaque on the 
abdomen. Microscopically, a primary melanoma with an ulcer and skin infiltration of CLL/SLL at the 
ulcer base was seen.  
Conclusion: Secondary cutaneous neoplasms can develop in patients with CLL/SLL and CLL/SLL 
infiltration can be associated with melanoma as in our case. The finding of a dense infiltrate of 
lymphocytes in cutaneous tumors should raise possibility of CLL/SLL and lead to a detailed 
examination. 
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Introduction 
Chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) is the most common 
leukemia of adults in Western countries. It is predominantly a disease of elderly patients and most 
are asymptomatic at the time of diagnosis.  
Patients with CLL/SLL are at greater risk for other malignancies [1,2]. Skin, prostate, breast, 
lung tumours, melanoma, and lymphoma are examples for the second primary tumours encountered 
in patients with CLL/SLL. These tumors usually do not share the same site with CLL/SLL 
infiltrations [2]. Cutaneous infiltrates of CLL/SLL have been reported mostly in association with 
squamous cell carcinoma (SCC), basal cell carcinoma (BCC) and actinic keratosis.  
We present a patient with skin involvement of CLL/SLL in which primary melanoma was observed.  
To the best of our knowledge, these findings represent the first reported case of CLL/SLL skin 
infiltration together with a primary melanoma occurring at the same place.  
Case presentation 
An 80-year-old male with a history of chronic lymphocytic leukemia/small lymphocytic lymphoma 
(CLL/SLL) presented with 3 cm nonpigmented, erythematous, infiltrated and ulcerated plaque on 
the abdomen. The patient stated the lesion had been present for three years. Clinically, the lesion 
was suspected to be skin infiltration of CLL/SLL. There was no personal or family history of 
melanoma. A shave biopsy was obtained.  
Microscopic examination at scanning view revealed an ulcer on the surface and a dense infiltration 
of monotonous small lymphocytes at the bottom. On higher magnification, increased 
vascularization and neutrophilic infiltrate was seen at the base of ulcer and a spindle cell tumor was 
noticed between this inflammatory reaction and deep dermal infiltrate (Fig. 1).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1 Ulcerated melanoma on the surface and dense infiltration of chronic lymphocytic 
leukemia/small lymphocytic lymphoma at the shave biopsy (1A: H&E x100, 1B: H&E x40) 
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This tumour cells were composed of enlarged hyperchromatic nuclei and spindle or epitheloid  
cytoplasm and were found to be associated with confluent atypical melanocytes placed at the basal 
layer of the epidermis. Pagetoid spread was seen as single cells or cell groups and loss of cohesion 
was present in junctional nests. Squamous metaplasia in eccrine ducts was also present. The 
immunohistochemical profile revealed strong positivity for S100 and HMB-45 in the spindle cells 
near the ulcer. 
CD20, CD5, bcl-2 and CD23 highlighted dense infiltration of small lymphocytic cells at the 
bottom of the lesion. CD3, CD10 and cyclin D1 were negative in these cells (Fig. 2).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2A: HMB-45 positivity, 2B: S100 positivity in melanoma cells, 2C: CD20 and 2D: bcl-2 positivity 
in leukemic cells (x40) 
 
Based on the above-described morphological and immunohistochemical features, the dense 
lymphoid infiltration was interpreted as CLL/SLL infiltration and the accompanying spindle cell 
tumour was interpreted as a melanoma.  
The patient was treated with wide local excision and an axillary lymph node was excised. 
Grossly, a 2.1 cm, poorly circumscribed, tan-brown lesion was seen with a centrally located ulcer 
(Fig. 3).  
Sections stained with hematoxylin and eosin showed broad proliferation of melanocytes with 
enlarged hyperchromatic nuclei on the surface. The melanocytes were arranged as solitary units and 
nests along the dermal epidermal junction. Foci of invasion were seen at the dermal part. Dense 
leukemic infiltration was seen along the tumour at the bottom of the melanocytic lesion. The 
thickness of the melanoma was 0.77 mm, and the Clark stage was III.  
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Figure 3A: Poorly circumscribed, tan-brown tumor with a centrally located ulcer, 3B: Tumor at the excision 
material (H&E x200), 3C-3D: Chronic lymphocytic leukemia/small lymphocytic lymphoma at the axillary 
lymph node (H&E x40 and x200). 
 
No melanocytic tumor metastasis was seen in the axillary lymph node, but the lymph node 
architecture was totally effaced with small lymphoid cell infiltration consistent with CLL/SLL (Fig. 
3), both morphologically and immunophenotypically with CD20, CD5, CD23 and bcl2 positivity.  
Discussion 
Chronic lymphocytic leukemia/small lymphocytic lymphoma is the most common leukemia of 
adults in western countries. It usually has an indolent clinical course and most patients are 
asymptomatic. The incidence rate increases with age with a mean age of 65 years at diagnosis  [3]. 
Malignant melanoma, however, is a primary tumour of the skin that can indicate a highly 
aggressive prognosis with regard to its clinical and histological characteristics, and with a high 
incidence of local or distant metastasis. Its prevalence also increases in older ages.  
Second primary malignancies can be found in patients with a primary tumour [1]. Different 
secondary tumours can be seen in cases with CLL/SLL prior to or following the disease. The 
prevalence has been reported as 10-20% in the literature. Skin, prostate, breast, and lung tumours, 
melanoma, lymphoma, and gastrointestinal tumours are some examples of second primary tumours 
[1, 2, 4]. 
 
Adami et al. [5] studied a total of 560000 patients including approximately 174000 cases with 
CLL/SLL and reported that CLL/SLL patients had a relative melanoma risk of 3.1. Landgren et al. 
[6] determined the relative melanoma risk as 1.19 in 7764 patients with CLL/SLL in their study in 
which 41181 lymphoma cases were screened in terms of secondary malignancies. In a survey 
carried out in 12452 patients with non-Hodgkin Lymphoma, Brennan et al. [7] established 
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melanoma as a secondary tumour in 93 cases and stated its standardized incidence ratio as 2.38.
 
Brennan et al. [8] emphasized that melanoma could be seen as a second primary malignancy in 
CLL/SLL patients, and also that CLL/SLL could be the second primary in melanoma patients.   
Distinct secondary tumours can be observed in patients with melanoma. Tumour types other than 
lymphoma with proven association with melanoma in the same patient are breast and prostate 
tumours and colorectal carcinomas [9-11].
 
Community-based studies have shown an increased 
incidence of secondary CLL/SLL in patients with metastatic melanoma [12, 13].
 
Melanoma may 
occur, before, at the same time, or after the lymphoma [4-8, 12-14].  
Verwer et al. [14] evaluated 18226 cases with melanoma and found 55 patients (0.3%) who had 
lymphoma together with melanoma. The most common subtype was chronic lymphocytic 
leukemia/small lymphocytic lymphoma (49.1%). Lymphoma was diagnosed subsequent to 
melanoma in 41.8% patients, prior to melanoma in 12.7% patients, and concurrently with 
melanoma in 45.5%. 
Farma et al. [2] presented 52 melanoma cases with chronic lymphocytic leukemia (CLL). The 
presence of melanoma was determined before the CLL diagnosis had been made in 32 cases (62%), 
and after the CLL diagnosis in 7 cases. In the same study, 22 patients (42%) had CLL on sentinel 
lymph node biopsy for their melanoma, and 5 of them had evidence of collision of metastatic 
melanoma and CLL in the sentinel lymph node [2]. 
 
A number of hypotheses have been suggested as the reason for the association of melanoma and 
lymphoma (CLL/SLL). One is that frequent and comprehensive follow-up of patients for the 
primary tumour can lead to an increased incidence of secondary malignancies [4]. The second is 
that both melanoma and CLL/SLL cells show abnormalities in chromosome 9p21 [4, 15]. Another 
assumption is that the impairment of lymphocyte-macrophage response can be a potential reason in 
patients with immunodeficiency [15]. Environmental factors such as sunrays, and distinct chemical 
products have also raised the incidence of melanoma and different lymphoma types. Ultraviolet 
light reduces T cell activity in various ways and promotes the incidence of lymphoma and other 
skin malignancies [4, 5, 15]. 
 
The present case is an example of cutaneous melanoma appearing after a 4 -year history of 
CLL/SLL. The difference of our case from the others in literature was the observation of dense 
leukemic infiltration masquerading as melanoma clinically and histologically at first glance at the 
base of the leukemic infiltration. 
There are a few articles on two different tumours occurring at different periods, and also case 
reports concerning melanoma metastasis and CLL/SLL infiltration in the same lymph nodes in the 
literature [2, 4-8, 12-14].  
The lesions known as leukemia cutis can be traced in hematological malignancies such as leukemic 
skin infiltration, myeloid sarcoma or granulocytic sarcoma composed of granulocytic or monocytic 
precursor cells, B- or T- cell lymphoblastic lymphomas or CLL/SLL [16, 17]. Specific skin lesions 
in CLL/SLL can emerge with particular clinicopathological features in the form of solitary, 
localized or generalized papules, nodules or plaques due to distinctive underlying diseases [18].
 
Although direct skin infiltration is rare in patients with CLL/SLL, it can be seen in inflammatory or 
neoplastic lesions in the skin areas with chronic antigenic stimulation [16, 19] such as 
inflammatory conditions, infectious diseases such as Borrelia and Herpes or primary epithelial 
neoplasia [16, 18, 20-22]. Skin involvement of CLL/SLL extending from cutaneous epithelial 
tumours to SCC, BCC and actinic keratosis has been defined in a limited number of articles as case 
reports [19, 20, 23]. These leukemic infiltrations are in the form of grouped small, monotonous 
lymphocytes in the dermis adjacent to skin tumour [23].
 
It is reported that malignant lymphocytes 
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come to the tumoral area as a host response to the secondary tumour and do not aggravate the 
prognosis of the patient in terms of lymphoma [19, 20].  
No other kind of skin lesion was determined in our 80-year-old patient with a history of 
CLL/SLL. Observation of leukemic infiltration intensifying around the melanoma that developed 
afterwards supports the mechanisms stated in the preceding literature. Leukemic infiltration around 
non-melanomatous tumours has been described in articles. However, there is no typical reference 
concerning intensive leukemic infiltration developing around a melanoma as seen in our case.  
Conclusion 
We presented a CLL/SLL patient with skin infiltration, diagnosed also as primary melanoma in the 
same area and with same biopsy, which has not been encountered in the literature previously to the 
best of our knowledge. Considering that secondary malignancies may occur in cases with CLL/SLL, 
the likelihood should also be assessed in the follow-up with biopsies of the cases in question. Care 
must be taken during the histopathological evaluation in this respect and further verification 
obtained by immunohistochemical analysis when suspicion exists.  
Consent  
We confirm that the patient has given their informed consent for the case report to be published.  
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